輸入代號或公司名稱後按 Enter
LUNG

Pulmonx Corp

+0.02 (+1.07%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 醫療器材 · 外科與醫療器材SIC 3841
1.97USD90.1K成交股數84.6M市值本益比(近四季)1.0股價營收比-4.6%營收年增(近四季)2026-11-11下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收22.8M+1%20.6M-13%21.5M+5%23.9M+15%22.5M+20%23.8M+35%20.4M+19%20.8M+43%18.9M17.7M17.2M14.5M
營業成本5.0M4.5M5.5M6.7M6.2M6.2M5.4M5.5M4.8M4.6M4.5M3.9M
毛利17.7M+9%16.0M-9%16.1M+7%17.2M+12%16.3M+16%17.6M+35%15.0M+18%15.3M+45%14.1M13.0M12.7M10.6M
毛利率78.0%77.9%74.7%72.1%72.5%74.0%73.7%73.7%74.7%73.7%74.1%72.9%
研發費用5.0M4.9M4.8M5.3M4.8M4.0M3.7M5.6M4.2M4.2M5.7M4.3M
銷售管理費用21.8M24.1M25.6M26.7M26.1M27.0M25.4M25.3M24.4M24.0M23.5M22.7M
營業利益−9.1M-38%−13.0M-3%−14.4M+2%−14.8M-5%−14.6M+0%−13.4M-12%−14.1M-14%−15.6M-5%−14.5M−15.2M−16.4M−16.4M
營業利益率-39.8%-62.9%-66.9%-62.0%-64.6%-56.5%-69.3%-75.2%-77.1%-85.9%-95.6%-112.8%
稅後淨利−10.1M-30%−13.7M+4%−14.0M-1%−15.2M-1%−14.4M+5%−13.2M-12%−14.1M-13%−15.3M-3%−13.7M−14.9M−16.2M−15.9M
淨利率-44.3%-66.3%-64.9%-63.6%-64.1%-55.4%-69.4%-73.7%-72.9%-84.3%-94.2%-109.1%
稀釋 EPS-0.24-33%-0.330%-0.34-6%-0.38-3%-0.360%-0.33-15%-0.36-16%-0.39-7%-0.36-0.39-0.43-0.42
稀釋股數42.5M41.9M40.9M40.4M40.0M39.1M39.3M38.9M38.6M38.1M37.8M37.6M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金55.8M61.6M76.5M75.5M74.6M70.9M63.3M63.5M70.2M94.9M102M110M
應收帳款12.2M10.8M13.8M15.9M14.0M13.1M11.7M11.1M10.5M10.1M8.9M8.2M
存貨16.4M16.3M16.2M16.2M16.8M16.9M17.0M17.0M17.2M16.1M15.6M15.6M
總資產115M120M138M147M151M163M167M173M165M185M193M201M
有息負債37.4M37.2M37.0M37.0M29.4M34.0M37.1M37.1M32.0M37.2M37.1M37.2M
總負債75.5M74.2M78.2M78.1M73.1M77.0M73.5M71.4M54.1M59.3M59.2M57.3M
股東權益39.2M45.8M60.0M69.1M77.7M85.8M93.9M101M110M126M134M144M
負債比65.8%61.9%56.6%53.1%48.5%47.3%43.9%41.4%32.9%32.0%30.6%28.5%
淨現金(現金 − 有息負債)18.4M24.4M39.5M38.5M45.2M36.9M26.2M26.4M38.2M57.8M64.4M73.2M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流−10.1M−13.2M+12%−11.8M−12.6M
資本支出9K301K451K61K
自由現金流−10.1M−13.5M+10%−12.2M−12.7M
折舊攤銷
買回庫藏股
現金股利
自由現金流率-49.1%-60.0%-65.0%-87.4%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

地區2025 年度 · 90.5M
美國57.0M63.0%+1.0%
歐洲中東非洲27.0M29.8%+20.9%
亞太6.2M6.9%+40.3%
Other International Geographical Areas260K0.3%-53.2%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202590.5M+8.0%−54.0M-59.7%-1.33−32.8M
FY202483.8M+22.0%−56.4M-67.3%-1.44−33.0M
FY202368.7M+28.0%−60.8M-88.6%-1.60−38.4M
FY202253.7M+10.8%−58.9M-109.8%-1.59−46.4M
FY202148.4M+47.9%−48.7M-100.5%-1.35−45.1M
FY202032.7M+0.4%−32.2M-98.5%-3.16−31.5M
FY201932.6M+62.9%−20.7M-63.5%-11.66−21.5M
FY201820.0M−18.5M-92.4%-11.03−18.7M